Established in 1993, CMAX is one of Australia’s largest and most experienced clinical trial units, specialising in early-phase studies. Our state-of-the-art, 78-bed facility in Adelaide’s Bio-Med City supports Phase I-II trials, with over 200 first-in-human studies completed. With an impressive global regulatory history and a database of 55,000+ participants, we provide reliable, diverse participant recruitment for high-quality research. All studies are ICH GCP compliant and meet the requirements of the US FDA, EMEA, Japan’s MHW, and Health Canada. We are also US FDA-audited.